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Chondroitin sulfates have been implicated in the promotion and in the inhibition of axon growth. In the zebrafish embryo,
chondroitin sulfates are present at the interface of the somites and the notochord where spinal motor axons extend ventrally
to establish the midsegmental ventral motor nerves. Injection of chondroitinase ABC prior to motor axon outgrowth
effectively removed all chondroitin sulfate immunoreactivity and induced abnormal axonal outgrowth in many (39%) of the
ventral motor nerves. The most common abnormality was the formation of side branches, approximately half of which
extended posteriorly, the others anteriorly. The effect was specific to the removal of chondroitin sulfates, since injections
of vehicle solution or of heparinase III did not affect the ventral motor nerves. Electron microscopic examination
demonstrated that the injections caused no damage to spinal cord, somite, and notochord. This suggests that chondroitin
sulfates normally constrain the outgrowth of the ventral motor nerves. Consistent with this hypothesis, injections of
soluble chondroitin sulfates, either as a mixture or individually, led to truncated or missing ventral motor nerves.
Truncations were most frequent after injection of chondroitin sulfate-B (up to 23%) while chondroitin sulfate-A had a lesser,
and chondroitin sulfate-C no apparent, effect. © 2000 Academic Press
Key Words: chondroitinase ABC; heparinase; glycosaminoglycan; proteoglycan; axon guidance; recognition molecule;
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Segmentation of the peripheral nervous system (PNS) is a
characteristic feature of vertebrates. It corresponds to the
segmentation of the lateral plate mesoderm into somites. In
birds and mammals, motor axons extending out of the
spinal cord are channeled into the anterior half of each
somite. This is largely due to an inhibitory activity that
renders the posterior half of the somite inhospitable to axon
growth and appears to be mediated predominantly by the
posterior sclerotome (Keynes and Stern, 1988; Tannahill et
al., 1997). Candidate molecules to guide the outgrowth
have been identified but little is known about their role in
vivo (Davies et al., 1990; Oakley and Tosney, 1991; Landolt
et al., 1995; Fredette et al., 1996; Ring et al., 1996; Wang
and Anderson, 1997).
Because of its simplicity, the spinal motor system of the
zebrafish lends itself to the study of motor axon guidance.
The innervation of each myotome is supplied by three
motor nerves: the dorsal nerve innervates dorsal muscula-
ture, the medial nerve the musculature at the level of the
horizontal myoseptum, and the ventral nerve the ventral
musculature. With the exception of the medial nerve, found f
206nly in fish, the pattern of spinal nerves is typical of all
ertebrates (Fetcho, 1987). But while the ventral roots in
ost vertebrates extend through the sclerotome of the
nterior hemisegment (Keynes and Stern, 1988), the roots
nd the ventral motor nerves of the zebrafish extend in a
idsegmental position, at the interface of somite and
otochord (Westerfield and Eisen, 1988; see also Bernhardt
t al., 1998). Reminiscent of the situation in birds and
ammals, an inhibitory activity in the posterior segment
alf probably contributes to the specification of the path-
ay (see below). There is no evidence, however, that the
nterior half of the fish somite is generally conducive to
otor axon outgrowth. Rather, the strict midsegmental
onfinement of the ventrally growing motor axons suggests
he existence of a narrow band of attractive cues and/or the
resence of inhibitory cues also in the anterior segment
alf.
Semaphorin Z1b (sema Z1b) mRNA is preferentially
xpressed in the posterior half of the somite (Bernhardt et
l., 1998; Roos et al., 1999) and is implicated in motor axon
uidance by experimental evidence: overexpression of sema
1b following injection of synthetic mRNA into freshlyertilized eggs led to missing or severely stunted ventral
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207Chondroitin Sulfates and Motor Axon Guidancemotor nerves in the majority of experimental embryos,
consistent with an inhibitory function of the protein (Roos
et al., 1999). This suggests that the normal expression
pattern of sema Z1b contributes toward the midsegmental
pathway choice of ventrally extending motor axons by
preventing them from invading the posterior somite half.
However, the incidence of inhibited motor axon growth in
each affected embryo was relatively low. In part this prob-
ably reflects the failure to overexpress the protein evenly
throughout the embryo. But it is equally probable that the
guidance of motor axons depends not on sema Z1b alone
but also on additional molecules.
Chondroitin sulfates might affect motor axon out-
growth in the zebrafish embryo. They are present at the
interface of somite and notochord, the environment
through which the ventral motor nerve extends, and may
contribute toward delimiting the midsegmental pathway
(Bernhardt et al., 1998). Three chondroitin sulfate struc-
tures are commonly found in vertebrate tissues: chon-
droitin sulfates-A and -C consist of repeating disaccha-
ride backbones containing D-glucuronic acid and
-acetylgalactosamine, sulfated at the 49, respectively at
he 69, position. The backbone of chondroitin sulfate-B
also referred to as dermatan sulfate) is formed by idu-
onic acid and 49-sulfated galactosamine.
Chondroitin sulfates can be repulsive, acting as barriers
o axonal growth. They are thought to mediate, at least in
art, the inhibitory effect of the posterior sclerotome on
hick motor axons (Oakley et al., 1994; Landolt et al., 1995;
Ring et al., 1996). They are present at the borders of the
barrel fields of the mouse somatosensory cortex (Crossin et
al., 1989) and in the roof plate of brain and spinal cord
(Snow et al., 1990a,b), regions avoided by growing axons.
Neurites growing from dorsal root ganglion cells in culture
avoid chondroitin sulfates (Carbonetto et al., 1983; Verna et
al., 1989; Snow et al., 1990a,b; Fichard et al., 1991). Accu-
mulation of chondroitin sulfates after lesioning the mam-
malian central nervous system (CNS) is thought to impede
axonal regeneration (McKeon et al., 1991; Davies et al.,
997, 1999). Neurite outgrowth by dissociated DRGs cul-
ured on sections of adult rat spinal cord or peripheral nerve
s enhanced after removal of chondroitin sulfates from the
ections (Zuo et al., 1998a,b). Chondroitin sulfates are
mplicated in directing the growth of mammalian retinal
anglion cell axons. These axons are thought to avoid high
evels of chondroitin sulfates near the retinal margin and to
ollow a decreasing gradient of chondroitin sulfates toward
he optic fissure. The stereotyped pattern of intraretinal
xon growth can be disturbed by treating retinal explants
ith an enzyme that removes the chondroitin sulfates
Brittis et al., 1992).
Chondroitin sulfates can also promote axonal growth.
s homogeneous cell culture substrates they can enhance
eurite outgrowth in vitro (Faissner et al., 1994; Clement
t al., 1998). They are present in the chick optic pathway
McAdams and McLoon, 1995) and in the cortical sub-
late (Sheppard et al., 1991; Bicknese et al., 1994; Emer-
Copyright © 2000 by Academic Press. All righting and Lander, 1996) at the time these are invaded by
xons, consistent with a role in promoting axonal
rowth. Their up-regulation in the lesioned PNS, con-
omitant with axonal regeneration, has been interpreted
s evidence for a growth-supportive role (Braunewell et
l., 1995). Addition of soluble chondroitin sulfates to
euroblastoma cells can overcome a 4b-phorbol 12b-
yristate 13b-acetate-induced block of neuritogenesis
Lesma et al., 1996). Chondroitin sulfate-A stimulates
the outgrowth of retinal ganglion cell axons from ex-
plants of goldfish retina (Challacombe and Elam, 1997).
Exposure of explanted retinae, with sclera and pigment
epithelium removed but with the lenses intact, to soluble
chondroitin sulfate-C results in the differentiation and
axonal growth of retinal ganglion cells at the ventricular
rather than the vitreal surface (Brittis and Silver, 1994).
Apparently the axons are stimulated to grow in the region
of maximal exposure to chondroitin sulfate-C.
The conflicting findings on the functions of chondroitin
sulfates may have several explanations: whether a particu-
lar chondroitin sulfate inhibits or enhances neurite out-
growth depends on its interactions with other substrates
(Dou and Levine, 1995). Different neuronal cell types can
react differently to chondroitin sulfates (Fernaud-Espinosa
et al., 1994; Dou and Levine, 1995; Garwood et al., 1999).
The core proteins, to which the glycosaminoglycans are
attached, influence neuronal behavior (Oohira et al., 1991;
Grumet et al., 1993; Dou and Levine, 1994; Maeda and
Noda, 1996; Garwood et al., 1999). It has finally been
suggested that some biological effects of chondroitin sul-
fates may be indirect, mediated by associated molecules,
e.g., growth factors (Emerling and Lander, 1996). A distri-
butional analysis of chondroitin sulfates in the embryonic
brain is consistent with the in vitro findings (Fernaud-
Espinosa et al., 1996): some of the developing fiber tracts are
surrounded by chondroitin sulfates which might channel
the growing axons. Other axonal pathways form in a chon-
droitin sulfate-rich environment, however, consistent with
a growth-promoting or permissive function. In conclusion,
the role of chondroitin sulfates during axonal outgrowth
appears to be complex and situation-dependent (Faissner
and Steindler, 1995).
The observation that zebrafish motor axons extend ven-
trally through an environment rich in chondroitin sulfate
reactivity (Bernhardt et al., 1998) suggests two possible
scenarios: chondroitin sulfates may be growth permissive
or alternatively their inhibitory activity may be overcome
locally by an unknown cue(s) that more directly specifies
the nerve trajectory. In the latter case a possible function of
chondroitin sulfates may be to ensure the tight fascicula-
tion of axons forming the muscle nerve. We have used
injection of the enzyme chondroitinase ABC, which selec-
tively and efficiently cleaves the chondroitin sulfates, and
injections of soluble chondroitin sulfate-A, -B, and -C to
test their function in vivo.
s of reproduction in any form reserved.
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208 Bernhardt and SchachnerMATERIAL AND METHODS
Animals. Zebrafish embryos were collected from our breeding
colony, maintained according to standard procedures (Westerfield,
1995). Embryos were kept at 28.5°C and staged in hours postfertil-
ization (hpf). The developmental age of experimental embryos was
confirmed by recording the position of the lateral line primordium
(prim-stage), an anatomical criterion of the embryonic stage (Kim-
mel et al., 1995).
Immunohistochemistry and in situ hybridization. Embryos
were anesthetized with 0.1% aminobenzoic acid ethyl methyl ester
(Sigma, St. Louis, MO) in phosphate-buffered saline (PBS; pH 7.4),
fixed (4% paraformaldehyde in PBS), and reacted as whole-mount
preparations (Bernhardt et al., 1990). Chondroitin sulfates were
detected using the rat monoclonal antibody (mAb) 473, which
recognizes chondroitin sulfate/dermatan sulfate epitopes (Faissner
et al., 1994; Braunewell et al., 1995; Clement et al., 1998). The
istributional data were confirmed using mAb CS-56 (Sigma),
hich recognizes chondroitin sulfate-A and -C. A panaxonal
arker, the mouse mAb to acetylated a-tubulin (Sigma), was used
to label spinal motor axons. Bound primary antibody was visual-
ized using HRP-conjugated secondary antibodies and the diamino-
benzidine reaction (Bernhardt et al., 1990). A mouse monoclonal
antibody against heparan sulfates (HepSS-1; Seikagaku, Tokyo,
Japan) was used to detect the respective antigen. An antibody
recognizing engrailed proteins (mAb 4D9; a gift from Dr. N. Patel,
University of Chicago, Chicago) was used to assess somite polarity
in embryos injected with chondroitinase ABC. Somite polarity was
also examined by in situ hybridization for zebrafish semaphorin
Z1b mRNA (Roos et al., 1999).
Enzymes. Chondroitinase ABC (Sigma or Seikagaku) was dis-
olved (2 U/ml) in 50 mM Tris–HCl (pH 7.85), 60 mM Na acetate,
ovine serum albumin (1 mg/ml) and stored as frozen aliquots.
eparinase III (heparitinase I; Sigma) was dissolved in the same
uffer (2 U/ml). To allow for the visualization of the injected liquid,
.5% of rhodamine–dextran (10000 MW; Molecular Probes, Eu-
ene, OR) was added to the enzyme solution.
Chondroitin sulfates. The chondroitin sulfates were dissolved
n the same buffer as the enzymes (see above) and injected either as
1:1:1 mixture of chondroitin sulfates-A, -B, and -C (Sigma; 25 or
0 mg/ml) or individually (25 mg/ml). Chondroitin sulfate-B was
dditionally tested at 5 mg/ml.
Injections. Embryos, at 14–16 hpf, were dechorionated in 10%
anks’ balanced salt solution (HBSS; Life Technologies, Eggen-
tein, Germany) and mounted on their left side in a drop of
ow-melting agarose (0.75% in 10% HBSS) on a microscope slide.
he dorsal edge of the embryo was freed from the agarose in order
o allow for access with a micropipette and the embryo was kept
oist under a drop of 10% HBSS. Under microscopic control a
icroelectrode was advanced with a micromanipulator lateral to
he spinal cord toward the interface of somite and notochord, on
he right side of the embryo. Using a picospritzer (Medical Systems
orp., Greenvale, NY) a small amount (approximately 10–20 nl) of
olution (see above) was injected at one or two locations (one in the
nterior trunk, one in the midtrunk). Assuming a volume of
pproximately 1 ml per embryo, this will have resulted in a final
chondroitinase ABC concentration of 0.02–0.04 U/ml. This com-
pares to an enzyme concentration of 1 U/ml used for comparable
studies in cell culture assays (Brittis et al., 1992; Emerling and
Lander, 1996). The final concentration of the chondroitin sulfate
mixture in the embryo is estimated at 0.25–0.5 mg/ml (injection
solution 25 mg/ml) or 0.05–0.1 mg/ml (injection solution 5 mg/
Copyright © 2000 by Academic Press. All rightml). This compares to a concentration of 10 mg/ml of culture
medium used in analogous studies performed on explanted nervous
tissue (Brittis and Silver, 1994; Anderson et al., 1998).
The injection site(s) was recorded, and the embryos were freed
rom the agarose and returned to individual dishes of 10% HBSS.
hey were kept at 28.5°C and analyzed after varying time intervals
2–16 h). Virtually all (.90%) of the embryos that had been injected
uccessfully and were not damaged during the transfer from the
icroscope slide into the HBSS survived to analysis, irrespective of
hether they had been injected with enzyme, soluble chondroitin
ulfates, or vehicle solution. Injected embryos sometimes appeared
o develop a little bit more slowly than unmanipulated littermates
as assessed by the prim-stage) but the delay was no more than 2 h
t 27–30 hpf. If this was the case, the developmental age of the
mbryos, indicated in hpf throughout this study, was corrected
ccordingly.
Preparation of semithin and ultrathin sections. Embryos in-
ected with chondroitinase ABC (Sigma; as above) were fixed at
8–22 hpf with 2% paraformaldehyde, 3% glutaraldehyde, 1%
crolein, and 1% dimethyl sulfoxide in 0.1 M phosphate buffer (PB,
H 7.4) for 1–2 h, washed in PB, and postfixed in 1% OsO4 in PB for
2 h. After being washed with PB and rinsed with water, the
preparations were stained en bloc with 2% uranyl acetate in water,
then washed in water, dehydrated through an alcohol series, and
embedded in plastic (Spurr). Semithin sections (1–2 mm) were cut
nd collected on microscope slides, stained with toluidine blue,
nd examined light microscopically. Ultrathin sections were col-
ected on one-hole grids coated with a Formvar film. Before
xamination the sections were stained on the grids with Reynold’s
ead citrate. Electron micrographs were taken with a Zeiss EM 10C
lectron microscope. Three chondroitinase ABC-treated embryos
ere examined after semithin sectioning and at the electron
icroscope level.
Scoring. To analyze the effects of chondroitinase ABC treat-
ent on motor axon outgrowth, embryos ages 25–30 hpf were
mmunostained with the tubulin antibody to visualize axons. At
he same time, embryos were also reacted with mAb 473 to
onfirm the absence of chondroitin sulfate immunoreactivity.
fter successful chondroitinase ABC treatment the ventral motor
erves often showed abnormal side branches, which sometimes
ere truncated or appeared to be missing. We first determined how
any of the embryos lacking detectable amounts of chondroitin
ulfates showed abnormal ventral motor nerves (Table 1). We next
etermined the incidence of the abnormalities in trunk segments
–14, restricting the score to embryos in which the incidence of at
east one abnormal ventral motor nerve proved that a critical
mount of chondroitin sulfates had been removed and in which the
ntire series of segments could be scored on at least one body side
Table 2). Segments 7–14 were chosen because the ventral motor
erves can be expected to have extended beyond the ventral edge of
he notochord even at the youngest developmental stages exam-
ned (compare Roos et al., 1999). This prerequisite to score trunca-
ions, which were defined as ventral nerves that had not extended
eyond the horizontal myoseptum (at notochord level), is not
lways fulfilled in more posterior segments of relatively young
25–27 hpf) embryos. We did not score more anterior segments
ecause overlying yolk sometimes obscured the motor nerves. In
rder to determine whether the abnormal ventral nerve branches
nduced by chondroitinase ABC treatment (as listed in Table 2)
xtended preferentially into the anterior or posterior somite half we
lso scored their directionality. These values are given in Table 3.To analyze the effects of injecting soluble chondroitin sulfates,
s of reproduction in any form reserved.
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209Chondroitin Sulfates and Motor Axon Guidanceeither as a mixture or individually (see above), we examined
embryos that had developed to 34–36 hpf. The analysis was the
same as after chondroitinase ABC. It proved impossible, however,
to distinguish successfully injected embryos using mAb 473. In the
injected embryos, the antibody caused considerable background
staining, probably reflecting the widespread presence of chon-
droitin sulfates. This obscured the anti-tubulin labeling and inter-
fered with the tracing of the motor axons. The percentage of
animals showing at least one abnormal ventral motor nerve (Table
1) was therefore determined as the proportion of the total number
of animals injected. The frequency of particular types of abnormali-
ties (branched and truncated or missing nerves) was determined in
trunk segments 7–14, restricting the score to embryos in which the
incidence of at least one abnormal ventral motor nerve proved that
a critical amount of chondroitin sulfate had been injected (Table 2).
The significance of the differences in the incidence of specific
abnormalities within the different treatment groups and listed in
Tables 1–3 (chondroitinase ABC-treated animals; the control group
of untreated, vehicle solution, and heparitinase III injected animals;
animals injected with chondroitin sulfates) was determined using
the x2 test to determine Fisher’s exact P value.
Because the embryos analyzed for the effects of soluble chon-
droitin sulfates were on average 4–5 h older than the embryos
analyzed after injection of chondroitinase ABC, their ventral motor
nerves should have extended beyond the ventral edge of the spinal
cord in the trunk segments 15–20 also. This was confirmed by the
examination of 10 uninjected embryos (120 of 120 ventral nerves).
It was therefore possible to determine the percentage of abnormal
ventral motor nerves also in these segments. The values are given
in the text.
A second motor nerve has formed in embryos of the stages
examined. It splits off the ventral root shortly after exiting the
spinal cord and extends into the dorsal somite. This dorsal motor
nerve extends just superficial to the spinal cord and is very difficult
to trace because of the tubulin immunoreactivity in the underlying
spinal cord. Therefore we did not systematically examine the
dorsal nerves in experimental embryos, except in two cases of
embryos injected with chondroitinase ABC (Seikagaku). In these
embryos the incidence of abnormal ventral motor nerves proved
that a critical amount of chondroitin sulfates had been removed,
and the entire series of segments 7–14 could be scored on both the
left and the right body sides. The values are given in the text.
RESULTS
The pioneering axons that establish the spinal motor
nerves leave the midtrunk spinal cord (segments 7–14) at
approximately 17–19 hpf. By 24–25 hpf they have estab-
lished the dorsal and ventral nerve trajectories. Follower
axons exit the spinal core and add onto the pioneers,
forming the dorsal and the ventral motor nerves. A distinct
medial nerve is first observed after 40 hpf (Myers et al.,
986). Previous work has demonstrated that the ventral
erve forms midsegmentally at the interface of notochord
nd somite, in an environment rich in chondroitin sulfates
Bernhardt et al., 1998). Migrating cells of putative sclero-
omal origin also extend at this interface, in the posterior
alf of each trunk segment. The relationships between the
entral motor nerve, the notochord, the somite, and the
igrating cells are summarized in Figs. 1A (a cross section), s
Copyright © 2000 by Academic Press. All rightB (a horizontal section at notochord level), and 1C (a
ateral view).
Immunohistochemistry confirmed the presence of chon-
roitin sulfates in the environment of the forming ventral
otor nerve (Fig. 2). At low magnification, chondroitin
FIG. 1. Schematic illustration of the ventral motor nerve pathway
in a 24-hpf embryo. (A) In cross section, chondroitin sulfate
reactivity (light gray shading) is found around the spinal cord (sc)
and at the interface between notochord (nc) and somite (so). The
ventral motor nerve extends at this interface. (B) In a horizontal
section, at the level of the notochord (anterior to the top), chon-
droitin sulfate reactivity is additionally found at the segmental
myosepta (m) and around migrating cells of putative sclerotomal
origin (s) that insert between the myotome and the notochord in
the posterior half of each segment. The nerves (arrows) extend near
the anterior edge of the migrating cells, in the chondroitin sulfate-
rich environment. (C) In a lateral view of a body segment, the
ventral nerve extends midway between the segmental myosepta,
chondroitin sulfate reactivity extends along the anterior–posterior
extent of the body segment, and putative sclerotome cells are found
in the posterior hemisegment (dark gray diamonds).ulfate reactivity appeared particularly conspicuous in the
s of reproduction in any form reserved.
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210 Bernhardt and Schachnerposterior half of each trunk segment (Fig. 2A, a dorsal view
of an 18-hpf embryo labeled by mAb 473). Sectioning
revealed this reflected chondroitin sulfate reactivity around
cells inserted between the myotome and the notochord (Fig.
FIG. 2. The distribution of chondroitin sulfate immunoreactivity i
are shown by immunostaining using mAb 473. (A, D, and E) Whole-
in D and E dorsal is to the top. (A) A low-power dorsal view of an 18
posterior half of each somite, adjacent to the notochord (n). The se
22-hpf embryo reveals chondroitin sulfate reactivity around the no
and in the segmental myosepta (arrowhead). (C) A high-power view
of the ventral motor nerve (labeled by the tubulin antibody, circled
which appears relatively faint in this doubly labeled preparation. A c
which the axons grow are surrounded by chondroitin sulfates. (D) A
reactivity in the segmental myosepta. (E) Similar view of a cor
chondroitin sulfate reactivity can be detected. Magnification bar: 1
IG. 3. Ventral motor nerves are revealed by immunostaining fo
(D–G). Lateral views of whole-mount preparations, anterior is to th
ventral motor nerve. (A) Ventral motor nerves (somites 7–9, left
uninjected embryo (26 hpf). (B) Anti-tubulin staining does not revea
are ventral motor nerves 8 and 9, left). (C) Ventral motor nerves (7
solution. (D) Abnormal side branches have formed in two ventr
chondroitinase ABC (Sigma). (E) Same embryo as in (D), abnormal
(F) Abnormal side branch in a ventral motor nerve (10, left) in an em
side branches in two ventral nerves (9 and 11, right) in an embryo
50 mm for (A–E), 30 mm for (F and G).2B, 22-hpf embryo). These cells have previously been iden- s
Copyright © 2000 by Academic Press. All rightified as putative sclerotome cells that originate in the
entral somite and migrate dorsally, inserting between the
yotome and the notochord (Bernhardt et al., 1998). The
ections also demonstrated the presence of chondroitin
zebrafish embryo and its elimination by chondroitinase treatment
nt preparations; (B and C) semithin sections. Anterior is to the left,
embryo shows accumulation of chondroitin sulfate labeling in the
ntal myosepta are also labeled. (B) A horizontal section through a
ord (asterisk), around putative migrating sclerotome cells (arrows),
horizontal section through a 24-hpf embryo shows the relationship
utative migrating cells and chondroitin sulfate immunoreactivity
arison with B will confirm, however, that the migrating cells along
view of a 26-hpf embryo shows the prominent chondroitin sulfate
nding embryo injected with chondroitinase ABC at 16 hpf. No
m for (A), 25 mm for (B), 10 mm for (C), and 70 mm for (D and E).
tylated a-tubulin in control (A–C) and in experimental embryos
t, dorsal to the top. Arrows indicate abnormal side branches of the
nd without side branches along a midsegmental pathway in an
e branches at least up to 36 hpf in uninjected embryos (shown here
right) are unbranched in an embryo (26 hpf) injected with vehicle
otor nerves (8 and 10, left) in an embryo (26 hpf) injected with
branches have formed in three ventral motor nerves (8–10, right).
(26 hpf) injected with chondroitinase ABC (Sigma). (G) Abnormal
pf) injected with chondroitinase ABC (Sigma). Magnification bar:n the
mou
-hpf
gme
toch
of a
) to p
omp
side
respo
00 m
r ace
e lef
) exte
l sid
–10,
al m
side
bryo
(26 hulfates in the anterior segment half, between the somite
s of reproduction in any form reserved.
211Chondroitin Sulfates and Motor Axon Guidanceand the notochord. The distribution pattern remained es-
sentially unchanged up to at least 30 hpf (the latest time
point examined; data not shown). Double labeling with
mAb 473 and anti-tubulin confirmed that the forming
ventral motor nerve was surrounded by chondroitin sulfate
reactivity (Fig. 2C) (Bernhardt et al., 1998). We conclude
that chondroitin sulfates are in a position to influence the
ventral growth of motor axons but that their presence in
both the anterior and the posterior segment halves makes
them unlikely candidates to directly specify the midseg-
mental axonal pathway.
Chondroitin sulfates can be removed from the environ-
ment of the ventrally growing motor axons by injecting the
enzyme chondroitinase ABC, which specifically cleaves
chondroitin sulfate-A, -B, and -C. Injections into zebrafish
embryos were performed at approximately 14 to 16 hpf, i.e.,
prior to motor axon outgrowth. Successful injections re-
sulted in the complete elimination of all chondroitin sul-
fate immunoreactivity as detected by mAb 473. This is
evident by the comparison of a 26-hpf control embryo and a
comparably staged experimental embryo 10 h after chon-
droitinase ABC injection (Figs. 2D and 2E). In the side view
of the control embryo, mAb 473 labeling is very distinct in
the segmental myosepta while the staining around the
sclerotome cells is not readily visible at this plane of focus
(Fig. 2D). In the experimental embryo, no labeling is de-
tected (Fig. 2E). Examination of embryos at different time
intervals indicated that chondroitin sulfates were removed
already at 2 h after injection (the earliest time point
examined) and that there was no recovery of immunoreac-
FIG. 4. Camera lucida tracings of the ventral motor nerves labeled
of embryos injected prior to 16 hpf with different enzyme prepara
ipsilateral, broken lines contralateral motor nerves. In A–C the che
motor nerves in segments 4–10 have extended normally in an em
branches have formed in segments 5–11 of an embryo (26 hpf) inje
seen in some of the ventral motor nerve in segments 9–15 of an e
embryo the dorsal motor nerves (arrowheads) could be traced on th
abnormal motor nerves are found in segments 5–11 of an embryo (2
somite borders were difficult to trace. Magnification bar, 50 mm.tivity up to 27 hpf. In 30-hpf embryos, labeling could
Copyright © 2000 by Academic Press. All rightsometimes be detected in the tail region, presumably re-
flecting new synthesis of the glycosaminoglycans (data not
shown), but continued to be absent from the trunk and head
region. These experiments show that it is possible to
efficiently remove chondroitin sulfates from zebrafish em-
bryos during the time period in which the ventral motor
nerve is established.
Removal of chondroitin sulfates led to the formation of
abnormal ventral motor nerves. After a survival interval of
10–15 h the chondroitinase ABC-treated embryos, now ages
25–30 hpf, were processed for tubulin immunohistochem-
istry to visualize axons. In contrast to control embryos of
the same age, which always had unbranched ventral motor
nerves (except for occasional bifurcations at levels ventral
to the notochord; Figs. 3A, 3B, and 4A), many of the
experimental embryos had ventral motor nerves that gave
rise to side branches. These abnormal side branches formed
immediately ventral to the exit of the nerve from the spinal
cord (Figs. 3D, 3G, and 4B), at the level of the horizontal
myoseptum (Figs. 3E–3G, 4B, and 4C), and near the ventral
edge of the notochord (Fig. 3E). Very severely affected
embryos showed numerous branches at all levels, with very
contorted trajectories (Fig. 4D). A less frequent abnormality
was the occurrence of truncated or missing motor nerves
(not illustrated). As can be seen in Table 1, approximately
50% of all embryos in which chondroitin sulfates had been
removed showed these abnormalities, the effectiveness of
the Seikagaku enzyme appearing somewhat higher (57%)
than that of the Sigma enzyme (44%).
The incidence of abnormal ventral motor nerves was
an antibody to acetylated a-tubulin in whole-mount preparations
. Side views, anterior is to the left, dorsal up. Solid lines indicate
-shaped somite borders are indicated by thin lines. (A) The ventral
(25 hpf) injected with heparinase III. (B) Numerous abnormal side
with chondroitinase ABC (Sigma). (C) Abnormal side branches are
yo (30 hpf) injected with chondroitinase ABC (Seikagaku). In this
ilateral (left) side of the embryo and appeared normal. (D) Severely
) injected with chondroitinase ABC (Seikagaku). In this animal thewith
tions
vron
bryo
cted
mbr
e ips
5 hpfdetermined in somites 7–14 of embryos in which the
s of reproduction in any form reserved.
d
m
t
r
s
t
b
r
t
g
C
C
N
V
H
C
C
C
C
C
m
i
n
i
A
a
d
e
r
m
t
T
D
212 Bernhardt and Schachnerpresence of at least one abnormal nerve confirmed that
chondroitin sulfates had been eliminated by the enzymatic
digestion (Table 2). In animals injected with the enzyme
from Sigma (n 5 9), 34% of the scored ventral motor nerves
were abnormal. In animals injected with the Seikagaku
enzyme (n 5 8), the incidence of abnormalities was 30%. A
minority of the nerves were truncated or missing (1% of the
nerves scored in animals injected with the enzyme from
Sigma and 6% of the nerves in animals injected with the
enzyme from Seikagaku; see Table 2). Truncated or missing
ventral nerves often occurred near the injection site or in
immediately adjacent somites, and some of them might
have been due to local damage caused by the micropipette.
The majority of the abnormal nerves was branched and
found in somites that were not directly affected by the
injections. The incidence of abnormal side branches was
33% after injection of the Sigma enzyme and 24% after
injection of the Seikagaku enzyme. There was no clear
tendency for the abnormal side branches to extend either
anteriorly or posteriorly (Table 3). Of 78 abnormal branches
that could be scored for directionality, 37 (47%) grew
toward the next anterior and 41 (53%) toward the next
TABLE 1
Incidence of Embryos with Ventral Motor Nerve Abnormalitiesa
Embryos
(total)
Embryos with
abnormalities
hondroitinase ABC
(Sigma) 22 9 (41%)
hondroitinase ABC
(Seikagaku) 14 8 (57%)
o injection 45 2 (4%)
ehicle solution 7 0
eparinase III 24 1 (4%)
hondroitin sulfate mix
(25 mg/ml) 21 16 (76%)
hondroitin sulfate A
(25 mg/ml) 8 2 (25%)
hondroitin sulfate B
(25 mg/ml) 7 6 (86%)
hondroitin sulfate B
(5 mg/ml) 8 7 (88%)
hondroitin sulfate C
(25 mg/ml) 8 0
Note. The difference in the incidence of embryos with abnor-
alities after treatment with the Sigma or the Seikagaku enzyme
s not significant (x2 test, see Materials and Methods). The differ-
ences in the incidences of abnormalities in the control group of
embryos (no injection, vehicle, heparinase III) are not significant.
The incidence of abnormalities observed after injection of the
chondroitin sulfate mix differs significantly from that observed
after injections of chondroitin sulfates A and C, but not from that
observed after injections of chondroitin sulfate B (25 and 5 mg/ml).
a Truncated nerves and nerves that were branched at the noto-
chord level were scored as abnormal.posterior segmental myoseptum. The removal of chon-
Copyright © 2000 by Academic Press. All rightroitin sulfates appeared to specifically affect the ventral
otor nerve. The dorsal motor nerves, even if difficult to
race in tubulin-labeled preparations because of tubulin
eactivity in the underlying spinal cord, were normal in
omites 7–14 of two embryos (32 dorsal branches scored)
hat had incidences of abnormal ventral nerves (Fig. 4C).
Several control experiments argue that the abnormally
ranched ventral motor nerves are specifically due to the
emoval of chondroitin sulfates. Injections of vehicle solu-
ion or of heparinase III did not result in abnormal out-
rowth by the ventral motor nerves (Table 2). The absence
TABLE 2
Incidence of Abnormal Ventral Motor Nerves in the Midtrunk
Region of Embryos with Abnormalities
Nerves scored
(total)a
Abnormally
branched
nerves
Severe
truncation
Chondroitinase ABC
(Sigma) 144 48 (33%) 2 (1%)
Chondroitinase ABC
(Seikagaku) 128 30 (24%) 8 (6%)
Chondroitin sulfate mix
(25 mg/ml) 208 1 (0.5%) 19 (9%)
Chondroitin sulfate A
(25 mg/ml) 32 0 2 (6%)
Chondroitin sulfate B
(25 mg/ml) 96 4 (4%) 22 (23%)
Chondroitin sulfate B
(5 mg/ml) 112 9 (8%) 6 (5%)
Note. The incidences of abnormally branched nerves after injec-
tions of the Sigma or Seikagaku enzymes are not significantly
different (x2 test). The difference in the incidence of truncations is
ot significant. The incidences of abnormally branched nerves after
njections of the chondroitin sulfate mix and of chondroitin sulfate
are not significant, they differ significantly from those observed
fter injections of chondroitin sulfate B (25 and 5 mg/ml). The
ifferences in the incidences of truncations are not significant,
xcept for chondroitin sulfate B (25 mg/ml). For details see Mate-
ials and Methods.
a Ventral motor nerves 7–14 were scored in embryos showing
otor nerve abnormalities (as listed in Table 1). In some embryos
he score could be obtained only for one body side.
ABLE 3
irection of Abnormal Branchesa
Anterior Posterior
Chondroitinase ABC (Sigma) 23 (48%) 25 (52%)
Chondroitinase ABC (Seikagaku) 14 (47%) 16 (53%)
Note. The differences in the incidences of abnormalities are not
significant (x2 test, for details see Materials and Methods.a Same data set as in Table 2.
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213Chondroitin Sulfates and Motor Axon Guidanceof an effect after heparinase III treatment was expected as an
antibody to heparan sulfate yielded no conspicuous immu-
nolabeling throughout the trunk of control embryos (not
injected with heparinase III). Nevertheless, this finding
argues that injection of an enzyme capable of degrading
sulfated carbohydrate structures does not necessarily lead
to abnormal motor axon outgrowth. The absence of wide-
spread structural damage was confirmed by the light and
electron microscopic examination of embryos injected with
chondroitinase ABC. Semithin sectioning demonstrated
that somites, spinal cord, and notochord had developed
normally in three experimental animals (compare Figs. 5A
and 5B). Ultrastructural analysis of these embryos con-
firmed that there was no apparent damage of the interface of
somite and notochord, the site of ventral extension of the
motor nerve. The medial surface of the somite, the extra-
cellular matrix (ECM) separating somite and notochord, and
the notochord itself all appeared intact (Fig. 5C). It is clear
that the injections caused no general damage and likely that
FIG. 5. Light and electron micrographs of cross sections through t
hrough an uninjected embryo (A). In the injected embryos chondr
onfirmed by immunostaining in order to ensure good ultrastructu
tained with toluidine blue. s, spinal cord; n, notochord; asterisks
vidence of nonspecific damage in the spinal cord, notochord, and s
lectron micrograph shown in (C) that illustrates another embryo.
evel of the horizontal myoseptum. The microenvironment through
amage. In particular the basal lamina (between arrowheads) that se
he medial surface of the somite (between arrows). Within the somit
f actin filament clusters (a). Magnification bar: 25 mm for (A andthe chondroitinase ABC had no deleterious effects. p
Copyright © 2000 by Academic Press. All rightFinally, we explored whether the internal organization of
he somite might be affected by the enzyme treatment. In
8- to 20-hpf embryos (n 5 9) injected with chondroitinase
BC at 14–16 hpf, semaphorin Z1b mRNA was localized
referentially in the posterior hemisomites, the normal
xpression pattern (not shown). Using an antibody to en-
railed proteins (mAb 4D9; Patel et al., 1989), we found that
mmunopositive nuclei of muscle pioneer cells occupied
heir expected locations in the anterior somite of 20- to
4-hpf embryos (n 5 5; not shown) that had been success-
ully injected with chondroitinase ABC (confirmed by the
bsence of mAb 473 immunoreactivity). Together these
ndings strongly argue against the possibility that the
bnormal nerve branches resulted from mechanical damage
o the embryo or other nonspecific effects.
The abnormal branching observed in ventral motor
erves of chondroitinase ABC-treated embryos suggests
hat the role of chondroitin sulfates might be in confining
he ventrally extending axons to a narrow midsegmental
2-hpf embryos injected with chondroitinase ABC (Sigma; B, C), and
sulfates are expected to be missing even if their absence was not
reservation. (A) A semithin section through an uninjected embryo
ite. (B) A semithin section stained with toluidine blue shows no
e (labeled as in A). The box indicates the approximate frame of the
lectron micrograph of the interface of somite and notochord at the
ch the ventral motor nerve extends shows no evidence of structural
es the notochord from the somite (asterisks) appears intact, as does
scle cells have differentiated normally as indicated by the presence
mm for (C).wo 2
oitin
ral p
, som
omit
(C) E
whi
parat
e muath. If chondroitin sulfates were inhibitory, increasing
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214 Bernhardt and Schachnertheir concentration might be expected to adversely affect
axonal outgrowth. We tested this hypothesis by injecting a
mixture of chondroitin sulfate-A, -B, and -C into embryos at
14–16 hpf. Embryos were analyzed at 34–36 hpf. Injections
of nanoliter amounts of the chondroitin sulfate mixture at
concentrations of 25 and 10 mg/ml yielded similar effects
and the pooled data are presented in Tables 1 and 2. The
majority (76%) of the embryos showed abnormal ventral
motor nerves (Table 1). In segments 7–14, 9% of the ventral
motor nerves were truncated (Fig. 6A), and one nerve was
abnormally branched (Table 2). Most of the truncated
nerves were observed far from the injection sites, and thus
truncation cannot be explained by mechanical disruption
caused by the micropipette.
We additionally determined the incidence of abnormal
ventral motor nerves in segments 15–20 after an initial
examination suggested an even higher incidence of abnor-
malities in the caudal trunk. In uninjected embryos of
34–36 hpf, these motor nerves had consistently extended
ventrally beyond the notochord. In embryos injected with
the chondroitin sulfate mix the incidence of abnormal
ventral motor nerves in segments 15–20 was 16% (n 5
156), and all nerves were truncated.
Injecting individual chondroitin sulfates (25 mg/ml injec-
tion solution) demonstrated the specificity of the observed
effect: chondroitin sulfate-C (Fig. 6B) caused no, and chon-
droitin sulfate-A (not shown) only few, abnormalities
FIG. 6. Ventral motor nerves are revealed by immunostaining fo
sulfates. Lateral views of whole-mount preparations, anterior is to
truncated or missing ventral motor nerves, arrows abnormal side br
led to truncated ventral motor nerves, illustrated are segments 1
mg/ml) has not affected the ventral motor nerves, illustrated are
sulfate-B (25 mg/ml) has induced truncated ventral motor nerves, i
Injection of chondroitin sulfate-B (5 mg/ml) has induced truncate
Magnification bar: 50 mm for (A, B, D), 100 mm for (C).(Tables 1 and 2). After application of chondroitin sulfate-B,
Copyright © 2000 by Academic Press. All rightowever, the majority (86%) of the embryos were abnormal
Table 1). In segments 7–14 of these embryos, 27% of the
entral motor nerves were abnormal, most (85%) of them
runcated (Table 2; Fig. 6C). Even at a concentration of 5
g/ml chondroitin sulfate-B still caused abnormalities in
8% of the injected embryos (Table 1). However, the
ncidence of abnormal ventral motor nerves in segments
–14 was lower (13%), and supernumerary branches were
ore frequent (60%) than truncations (Table 2; Fig. 6D).
ore caudal trunk segments were slightly more affected by
hondroitin sulfate-B injection than the midtrunk seg-
ents: after injection of chondroitin sulfate-B at 25 mg/ml
he percentage of abnormal ventral motor nerves in seg-
ents 15–20 was 28% (n 5 20 nerves; 11 missing, 9
ranched), after injection at 5 mg/ml it was 17% (n 5 16
erves; 9 missing, 7 branched).
DISCUSSION
The ventral motor nerves are formed by spinal axons that
extend in the chondroitin sulfate-rich environment be-
tween somite and notochord. The nerves grow in the
middle of each body segment and show no side branches up
to at least 40 hpf. Manipulating chondroitin sulfate levels
during the period of motor axon outgrowth affected their
formation. Removal of chondroitin sulfates by injection of
tylated a-tubulin in embryos injected with different chondroitin
left, dorsal to the top. Embryos are 32–34 hpf. Asterisks indicate
es. (A) Injection of the chondroitin sulfate mixture (25 mg/ml) has
on the right body side. (B) Injection of chondroitin sulfate-C (25
ents 10–15 on the right body side. (C) Injection of chondroitin
ated in this overview are segments 8–16 on the left body side. (D)
branched ventral motor nerves, illustrated are segments 11–16.r ace
the
anch
2–16
segm
llustr
d andchondroitinase ABC caused abnormal side branches. Injec-
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215Chondroitin Sulfates and Motor Axon Guidancetion of soluble chondroitin sulfate-B at a low concentration
partly mimicked this effect and additionally caused trunca-
tions of some ventral motor nerves. Truncated ventral
nerves were the prevalent abnormality observed after injec-
tions of chondroitin sulfate-B or of a chondroitin sulfate
mix at a higher concentration.
Several considerations argue that the observed abnor-
malities are a specific result of the elimination, respectively
of the addition, of chondroitin sulfates: (i) while we ob-
served frequent abnormalities among the ventral motor
nerves there was no evidence of abnormal dorsal nerves,
neither in animals injected with the chondroitinase ABC
nor in animals injected with soluble chondroitin sulfates.
This impression was confirmed in two embryos affected by
the removal of chondroitin sulfates in which all the dorsal
nerves could be analyzed in segments 7–14. (ii) While
injection of chondroitinase ABC led to abnormal ventral
nerves, no abnormalities were observed after injections of
vehicle solution or of the same active concentration of
heparinase III. In this context it is important to note that
heparinase III has been shown to have biological effects
when tested in a different system, using a similar approach:
the formation of the retinotectal projection in Xenopus was
isrupted after exposing brain explants to heparinase III
Walz et al., 1997). (iii) The injections of soluble glycosami-
oglycans revealed differences in the biological role of
ndividual chondroitin sulfates. While soluble chondroitin
ulfate-B affected the ventral motor nerves, application of
hondroitin sulfate-C at the same concentration did not
ead to abnormal motor axon outgrowth. The effect of
hondroitin sulfate-B was observed even after injection at a
ow concentration: injecting a solution of 5 mg/ml is
stimated to have resulted in an effective concentration of
0–100 mg/ml in the embryo. This final concentration is in
the lower range of the amounts used by studies that have
tested the function of chondroitin sulfates in vitro, either as
substrates or in their soluble form (Snow et al., 1990a;
Brittis and Silver, 1994; Lafont et al., 1994; Dou and Levine,
1995; Emerling and Lander, 1996; Challacombe and Elam,
1997; Anderson et al., 1998). (iv) A detailed examination at
the light and electron microscopic level revealed no evi-
dence of physical damage to the environment of the motor
axons.
The effects observed after manipulating the chondroitin
sulfate levels in the environment of the motor axons, i.e.,
branching and truncation of ventral motor nerves, are
reminiscent of those obtained in a recent study on the
function of chondroitin sulfates during the formation of
nerve tracts in embryonic Xenopus (Anderson et al., 1998).
After exposing brain explants to a mixture of chondroitin
sulfate-A and -C (10 mg/ml medium), Anderson et al. (1998)
observed abnormal outgrowth by a subset of axons that
extends relatively late during embryogenesis, after the basic
scaffold of tracts and commissures has already been estab-
lished by pioneering axons. These axons can be labeled
selectively by an antibody to a glycoform of the neural cell
adhesion molecule. They arise from the presumptive telen- d
Copyright © 2000 by Academic Press. All rightcephalon and extend through the postoptic commissure and
the contralateral tract of the posterior commissure (TPOC)
to the junction of TPOC and the ventral commissure (VC).
Here some of the axons cross back over the midline in the
VC, the others continue to grow caudally. In most brains
exposed to chondroitin sulfates these axons failed to enter
the VC. Some probably continued to grow in the TPOC,
which appeared diffuse rather than tightly fasciculated.
Some of the axons also abnormally exited the TPOC to
project dorsally. Others may have stalled. It appears, then,
that increasing chondroitin sulfate levels in the embryonic
Xenopus brain can both block axonal growth and lead to
abnormal axonal trajectories.
How do chondroitin sulfates exert their influence on the
ventrally growing motor axons? In the chick somite, the
proposed function of chondroitin sulfates is to prevent the
growth of motor axons into the posterior hemisegment
(Oakley and Tosney, 1991; Landolt et al., 1995; Ring et al.,
996). In the zebrafish, chondroitin sulfates are present not
nly in the posterior but also in the anterior segment half,
nd after their removal supernumerary nerve branches
xtend not only posteriorly but also anteriorly. These
bnormal branchings suggest that the function of chon-
roitin sulfates in the zebrafish somite is to constrain the
entral motor nerve to its midsegmental pathway. A role in
reventing axons from straying from their pathway is also
onsistent with the truncated ventral motor nerves that
ormed after injection of soluble chondroitin sulfates. This
onstraining function appears mediated mainly by chon-
roitin sulfate-B and to be concentration dependent: the
oncentrations normally present in the environment allow
xonal extension but enhance the fasciculation. Blocking
xonal outgrowth requires injection of additional chon-
roitin sulfates. This model is supported by in vitro findings
hat show chondroitin sulfate-B to mediate a concentration-
ependent inhibition of neurite outgrowth from cerebellar
ranule cells (Dou and Levine, 1995). That the elimination
f a surrounding inhibitor can allow for striking defascicu-
ation of peripheral nerves is apparent from the analysis of
ranial nerves in mice lacking semaphorin III/D (Taniguchi
t al., 1997).
The abnormal nerve branching that is observed occasion-
lly after injection of soluble chondroitin sulfates, in par-
icular at lower concentrations, is more difficult to explain.
t might represent the first manifestation of an avoidance
esponse, triggered by a critical concentration of chon-
roitin sulfates. The cause of this branching would differ
rom the one after chondroitinase ABC treatment. That one
olecule can both inhibit axonal advance and also induce
xonal branching is not unprecedented. Ephrin-A5, which
an inhibit axonal extension, can also induce the formation
f axonal branches from layer 6 cortical neurons (Castellani
t al., 1998). Slit is an ECM molecule that can inhibit
xonal advance, e.g., prevent inappropriate axonal crossing
f the CNS midline in Drosophila (Kidd et al., 1999). Slit is
lso able to induce extensive axonal branching by cultured
orsal root ganglion neurons when added to the medium
s of reproduction in any form reserved.
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216 Bernhardt and Schachner(Wang et al., 1999). It is not completely clear whether the
specific axonal responses to ephrin-A5 and to slit, namely
growth arrest or branch formation, are neuronal cell type
specific. But in principle it is possible for one axon to show
apparently opposite responses to a single signal: sema-
phorin III/D and the myelin-associated glycoprotein can
either attract or repel growing axons, the specific response
depending on intracellular cyclic nucleotide levels (Ming et
l., 1997; Song et al., 1997, 1998).
How can the specific model of chondroitin sulfate func-
ion be fitted into a more general model of motor axon
uidance in the zebrafish somite? If chondroitin sulfates
nsure the tight fasciculation of the axons forming the
entral motor nerve, what cues determine the midsegmen-
al location of the pathway? This task would have to be
ediated by molecules that show a more restricted distri-
ution than the chondroitin sulfates. Several guidance
olecules are specifically expressed in the posterior seg-
ent half (Tannahill et al., 1997). One example is sema
1b, which is capable of inhibiting motor axon outgrowth
n the zebrafish embryo (Bernhardt et al., 1998; Roos et al.,
999). T-cadherin (Fredette et al., 1996), ligands of the
ephrin family (Wang and Anderson, 1997), and a mouse
homolog of Drosophila slit (Brose et al., 1999; Yuan et al.,
999) are present in the posterior hemisomite of chick and
ouse, and they can repel motor axons in vitro. The
idsegmental trajectory of the ventral motor nerve in the
ebrafish may reflect a tendency of the axons to grow along
he anterior border of the repulsive posterior domain. The
ypothesis is consistent with cell culture experiments
howing that axons confronted with the border between a
ermissive and a repulsive substrate will bundle along the
order (Pesheva et al., 1993; Taylor et al., 1993; Schachner
t al., 1994).
The above model fits our experimental findings, with one
xception: it does not readily explain why, in view of the
ostulated presence of additional inhibitory cues, abnormal
entral motor nerve branches often extend posteriorly after
he removal of chondroitin sulfates. This unexpected find-
ng might be explained if chondroitin sulfates, in addition
o directly affecting axonal growth, also contributed indi-
ectly toward the correct localization of additional guidance
ues. Glycosaminoglycans have been suggested to play a
undamental role in organizing the ECM environment
Emerling and Lander, 1996). If chondroitin sulfates were
mportant in localizing specific guidance cues, then ma-
ipulating their distribution might lead to complex indirect
ffects. Evidence for an indirect role has been provided in a
tudy showing that attachment of dissociated thalamic
ells to slices of embryonic mouse cerebral cortex is layer
pecific and this specificity is mediated at least in part by
he chondroitin sulfates (Emerling and Lander, 1996). Treat-
ent of the slices with chondroitinase ABC or addition of
ree chondroitin sulfates to the medium decreases the
ttachment of thalamic cells to the subplate and simulta-
eously increases attachment to the cortical plate. In par-
llel with these changes are changes in neurite outgrowth g
Copyright © 2000 by Academic Press. All righty the thalamic cells. Thus, the normal role of chondroitin
ulfates appears to be permissive in the subplate and repul-
ive in the cortical plate. These observations have been
xplained by the hypothesis that biological effects of chon-
roitin sulfates can depend on other molecules that associ-
te with the glycosaminoglycans (Emerling and Lander,
996). A similar mechanism probably explains the effects of
eparan sulfates, elimination of which has been demon-
trated to disrupt target recognition by retinal ganglion cell
xons in exposed brain preparations of Xenopus embryos.
his effect appears to be indirect and due to the removal of
broblast growth factor 2 normally bound to specific hepa-
an sulfate side chains (Walz et al., 1997).
Tenascins, netrins, and semaphorins are candidate mol-
cules that might be indirectly affected in their localization
fter manipulating chondroitin sulfate levels. Tenascins are
nown to interact with proteoglycans, even if it is unclear
hether the interaction depends on the presence of chon-
roitin sulfate side chains (Grumet et al., 1996; Aspberg et
l., 1997; Chung and Erickson, 1997; Xiao et al., 1997;
ilev et al., 1998). On the basis of their expression patterns
wo zebrafish tenascins, tenascin-C (TN-C) and tenascin-W
TN-W), are candidates to complement chondroitin sulfate
unctions. TN-C mRNA is detected in the somite, TN-W in
utative sclerotome cells and, at lower levels, in the
omitic mesoderm. TN-C immunoreactivity shows a pat-
ern similar to that of chondroitin sulfates, but the distri-
ution of the TN-W protein is unknown. Tenascins have
een shown to affect axon growth in vitro but their in vivo
unctions are controversial (reviewed by Bartsch, 1996).
N-C has been proposed to inhibit motor axon outgrowth
n the chick (Tan et al., 1987, 1991) but this role has been
uestioned (Stern et al., 1989). Applications of TN-C anti-
odies have failed to affect embryonic chick motor axon
utgrowth (Yip et al., 1995), but have caused delayed motor
ndplate reinnervation after a peripheral nerve lesion in the
dult mouse (Langenfeld-Oster et al., 1994). No obvious
bnormalities are detected in the peripheral nerve trajecto-
ies of tenascin-C knockout mice (Saga et al., 1992; Forsberg
t al., 1996), but the peripheral nerve and neuromuscular
unctions of the adult mice appear abnormal (Cifuentes-
iaz et al., 1998). Netrins are secreted molecules with a
asic domain that might mediate binding to ECM, in
articular to sulfated proteoglycans (Litwack et al., 1995;
erafini et al., 1996). Zebrafish netrin-1a is expressed in the
omite by the muscle pioneer cells that are located at the
evel of the horizontal myoseptum and are contacted by the
otor axons (Eisen et al., 1986; Myers et al., 1986). This
uggests that netrin-1a might play a role in attracting motor
xons (Lauderdale et al., 1997), in keeping with their
iological function in many different systems (Kennedy et
l., 1994; Mitchell et al., 1996; Serafini et al., 1996).
ecreted semaphorins have a basic C-terminal tail which
ould mediate binding to components of the ECM (Luo et
l., 1993). Zebrafish sema Z1b is expressed in the posterior
omite and has been shown to inhibit motor axon out-
rowth in vivo (Roos et al., 1999). Mapping studies will
s of reproduction in any form reserved.
217Chondroitin Sulfates and Motor Axon Guidanceallow to explore whether these molecules are abnormally
distributed after manipulating chondroitin sulfate levels in
zebrafish embryos.
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